The main objective was to evaluate distance, intermediate, and near vision in patients who have undergone cataract extraction with bilateral implantation of a new trifocal diffractive intraocular lens (IOL), along with patient-reported outcomes (PRO). A total of 50 eyes from 25 patients after Asqelio Trifocal IOL (AST Products, Inc., Billerica MA, USA) implantation were assessed in this study.
View Article and Find Full Text PDF